239 related articles for article (PubMed ID: 33822956)
1. Pharmacological activation of SERCA ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice.
Nogami K; Maruyama Y; Sakai-Takemura F; Motohashi N; Elhussieny A; Imamura M; Miyashita S; Ogawa M; Noguchi S; Tamura Y; Kira JI; Aoki Y; Takeda S; Miyagoe-Suzuki Y
Hum Mol Genet; 2021 May; 30(11):1006-1019. PubMed ID: 33822956
[TBL] [Abstract][Full Text] [Related]
2. Truncated dystrophin ameliorates the dystrophic phenotype of mdx mice by reducing sarcolipin-mediated SERCA inhibition.
Tanihata J; Nagata T; Ito N; Saito T; Nakamura A; Minamisawa S; Aoki Y; Ruegg UT; Takeda S
Biochem Biophys Res Commun; 2018 Oct; 505(1):51-59. PubMed ID: 30236982
[TBL] [Abstract][Full Text] [Related]
3. Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy.
Wasala NB; Yue Y; Lostal W; Wasala LP; Niranjan N; Hajjar RJ; Babu GJ; Duan D
Mol Ther; 2020 Mar; 28(3):845-854. PubMed ID: 31981493
[TBL] [Abstract][Full Text] [Related]
4. Restoration of SERCA ATPase prevents oxidative stress-related muscle atrophy and weakness.
Qaisar R; Bhaskaran S; Ranjit R; Sataranatarajan K; Premkumar P; Huseman K; Van Remmen H
Redox Biol; 2019 Jan; 20():68-74. PubMed ID: 30296699
[TBL] [Abstract][Full Text] [Related]
5. Hsp72 preserves muscle function and slows progression of severe muscular dystrophy.
Gehrig SM; van der Poel C; Sayer TA; Schertzer JD; Henstridge DC; Church JE; Lamon S; Russell AP; Davies KE; Febbraio MA; Lynch GS
Nature; 2012 Apr; 484(7394):394-8. PubMed ID: 22495301
[TBL] [Abstract][Full Text] [Related]
6. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
7. Mechanical factors tune the sensitivity of mdx muscle to eccentric strength loss and its protection by antioxidant and calcium modulators.
Lindsay A; Baumann CW; Rebbeck RT; Yuen SL; Southern WM; Hodges JS; Cornea RL; Thomas DD; Ervasti JM; Lowe DA
Skelet Muscle; 2020 Feb; 10(1):3. PubMed ID: 32007101
[TBL] [Abstract][Full Text] [Related]
8. Drastic reduction of sarcalumenin in Dp427 (dystrophin of 427 kDa)-deficient fibres indicates that abnormal calcium handling plays a key role in muscular dystrophy.
Dowling P; Doran P; Ohlendieck K
Biochem J; 2004 Apr; 379(Pt 2):479-88. PubMed ID: 14678011
[TBL] [Abstract][Full Text] [Related]
9. SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models.
Mázala DA; Pratt SJP; Chen D; Molkentin JD; Lovering RM; Chin ER
Am J Physiol Cell Physiol; 2015 May; 308(9):C699-709. PubMed ID: 25652448
[TBL] [Abstract][Full Text] [Related]
10. Sarcolipin haploinsufficiency prevents dystrophic cardiomyopathy in
Mareedu S; Pachon R; Thilagavathi J; Fefelova N; Balakrishnan R; Niranjan N; Xie LH; Babu GJ
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H200-H210. PubMed ID: 33216625
[TBL] [Abstract][Full Text] [Related]
11. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
12. Lipogenesis mitigates dysregulated sarcoplasmic reticulum calcium uptake in muscular dystrophy.
Paran CW; Zou K; Ferrara PJ; Song H; Turk J; Funai K
Biochim Biophys Acta; 2015 Dec; 1851(12):1530-8. PubMed ID: 26361872
[TBL] [Abstract][Full Text] [Related]
13. Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice.
Voit A; Patel V; Pachon R; Shah V; Bakhutma M; Kohlbrenner E; McArdle JJ; Dell'Italia LJ; Mendell JR; Xie LH; Hajjar RJ; Duan D; Fraidenraich D; Babu GJ
Nat Commun; 2017 Oct; 8(1):1068. PubMed ID: 29051551
[TBL] [Abstract][Full Text] [Related]
14. Increasing muscle contractility through low-frequency stimulation alters tibial bone geometry and reduces bone strength in
Chan AS; Hardee JP; Blank M; Cho EH; McGregor NE; Sims NA; Lynch GS
J Appl Physiol (1985); 2023 Jul; 135(1):77-87. PubMed ID: 37262103
[TBL] [Abstract][Full Text] [Related]
15. Postdevelopmental knockout of Orai1 improves muscle pathology in a mouse model of Duchenne muscular dystrophy.
García-Castañeda M; Michelucci A; Zhao N; Malik S; Dirksen RT
J Gen Physiol; 2022 Sep; 154(9):. PubMed ID: 35939054
[TBL] [Abstract][Full Text] [Related]
16. Direct observation of failing fibers in muscles of dystrophic mice provides mechanistic insight into muscular dystrophy.
Claflin DR; Brooks SV
Am J Physiol Cell Physiol; 2008 Feb; 294(2):C651-8. PubMed ID: 18171725
[TBL] [Abstract][Full Text] [Related]
17. Intestine of dystrophic mice presents enhanced contractile resistance to stretching despite morphological impairment.
Alves GA; Silva LR; Rosa EF; Aboulafia J; Freymüller-Haapalainen E; Souccar C; Nouailhetas VL
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G191-9. PubMed ID: 24284964
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of Dp427-deficient mdx tissues shows that the milder dystrophic phenotype of extraocular and toe muscle fibres is associated with a persistent expression of beta-dystroglycan.
Dowling P; Lohan J; Ohlendieck K
Eur J Cell Biol; 2003 May; 82(5):222-30. PubMed ID: 12800977
[TBL] [Abstract][Full Text] [Related]
19. Exacerbation of dystrophic cardiomyopathy by phospholamban deficiency mediated chronically increased cardiac Ca
Law ML; Prins KW; Olander ME; Metzger JM
Am J Physiol Heart Circ Physiol; 2018 Dec; 315(6):H1544-H1552. PubMed ID: 30118340
[TBL] [Abstract][Full Text] [Related]
20. BGP-15 Improves Aspects of the Dystrophic Pathology in mdx and dko Mice with Differing Efficacies in Heart and Skeletal Muscle.
Kennedy TL; Swiderski K; Murphy KT; Gehrig SM; Curl CL; Chandramouli C; Febbraio MA; Delbridge LM; Koopman R; Lynch GS
Am J Pathol; 2016 Dec; 186(12):3246-3260. PubMed ID: 27750047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]